Literature DB >> 1403498

Pseudomembranous colitis following resection for Hirschsprung's disease.

C E Bagwell1, M R Langham, S M Mahaffey, J L Talbert, B Shandling.   

Abstract

Enterocolitis is the most common cause of significant morbidity and death in Hirschsprung's disease. Although most cases respond to nasogastric decompression, antibiotics, and colonic evacuation, some children have an unusually fulminant or protracted clinical course. Four cases are reported of pseudomembranous colitis (PMC) that developed 1 to 18 months (mean, 8 months) after definitive surgery for Hirschsprung's disease (Soave endorectal pull-though, 2; Duhamel procedure, 2). While all children presented with fever, abdominal distention, and diarrhea, indistinguishable from typical Hirschsprung's enterocolitis, the clinical course was fulminant in two cases, both of whom died of septic shock. Postmortem examination in both showed extensive colonic pseudomembranes despite identification of Clostridium difficile toxin and subsequent vancomycin therapy (initiated late in the clinical course). Two children in the series had protracted hospitalizations and eventually required diverting enterostomy despite recognition of C difficile toxin and treatment with enteral vancomycin, in one child necessitating multiple courses of antibiotic therapy. Awareness of the virulence of PMC associated with Hirschsprung's disease (even after definitive resection) should prompt submission of stool specimens from any child who presents with enterocolitis for both C difficile culture and toxin levels. On the basis of our experience it is our policy to initiate a prompt course of vancomycin by rectal lavage or nasogastric tube in all children with Hirschsprung's enterocolitis, pending culture results, in view of the significant morbidity and mortality exemplified by cases in this review.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403498     DOI: 10.1016/0022-3468(92)90269-d

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Unexpected mortality in pediatric patients with postoperative Hirschsprung's disease.

Authors:  Jin-Sheng Wang; Hung-Chang Lee; Fu-Yuan Huang; Pei-Yeh Chang; Jin-Cherng Sheu
Journal:  Pediatr Surg Int       Date:  2004-06-04       Impact factor: 1.827

Review 2.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

Review 3.  Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention.

Authors:  Farokh R Demehri; Ihab F Halaweish; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 4.  Recent developments in Hirschsprung's-associated enterocolitis.

Authors:  Elizabeth M Pontarelli; Henri R Ford; Christopher P Gayer
Journal:  Curr Gastroenterol Rep       Date:  2013-08

Review 5.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

Review 6.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

Review 7.  The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Authors:  D Mc Laughlin; F Friedmacher; P Puri
Journal:  Pediatr Surg Int       Date:  2014-07-10       Impact factor: 1.827

8.  The enteric nervous system promotes intestinal health by constraining microbiota composition.

Authors:  Annah S Rolig; Erika K Mittge; Julia Ganz; Josh V Troll; Ellie Melancon; Travis J Wiles; Kristin Alligood; W Zac Stephens; Judith S Eisen; Karen Guillemin
Journal:  PLoS Biol       Date:  2017-02-16       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.